New diabetes clinical trial: Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood | | |
New diabetes clinical trial: Enriched Eggs for Retina Health in Type 2 Diabetes | | |
New diabetes clinical trial: Intestinimonas for Prevention of Type 2 Diabetes Mellitus | | |
New diabetes clinical trial: Sitagliptin for the Treatment of Type 2 Diabetes | | |
New diabetes clinical trial: Influence of Diet on Pregnancy With Polyhydramnios | | |
New diabetes clinical trial: Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions | | |
New diabetes clinical trial: Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D) | | |
New diabetes clinical trial: Educational Intervention Targeting Statin Therapy and Compliance in Diabetic Patients | | |
New diabetes clinical trial: Wearable Technology and a Virtual Lifestyle Program for Type 2 Diabetics | | |
New diabetes clinical trial: Pilot Study to Assess the Effects of Hepatic Ultrasound Insonification on Subjects With T2DM | | |
New diabetes clinical trial: BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients | | |
New diabetes clinical trial: A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus | | Published on: August 06, 2020 at 07:00PM Condition: Type 1 Diabetes Interventions: Drug: Administration of BioChaperone insulin lispro reconstituted with Humalog® (IMP1); Drug: Administration of Ready-to-use BioChaperone insulin lispro (IMP2); Drug: Administration of US-approved Humalog® (IMP3); Drug: Administration of EU-approved Humalog® (IMP4) Sponsor: Adocia Recruiting https://clinicaltrials.gov/ct2/show/NCT04501107?term=diabetes&sfpd_d=14 August 06, 2020 at 02:24PM via ClinicalTrials.gov |
New diabetes clinical trial: Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes | | |
New diabetes clinical trial: "FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM) | | |
New diabetes clinical trial: Effectiveness of a Multimodal Intervention on Function in Older Frail People With Diabetes in Latinamerican | | Published on: August 07, 2020 at 07:00PM Conditions: Frailty Syndrome; Frail Elderly Syndrome; Diabetes Mellitus, Type 2 Interventions: Other: Multimodal intervention; Other: Usual care group Sponsors: Consorcio Centro de Investigación Biomédica en Red, M.P.; Pan American Health Organization; Catholic University of the Sacred Heart; Diabetes Frail Ltd; University of Castilla-La Mancha; Confederación Española de Organizaciones de Mayores (CEOMA); Pontificia Universidad Javeriana; Pontificia Universidad Catolica de Chile; Instituto de Geriatria, Mexico; Universidad de San Martín de Porres (USMP); Universidad de Santiago de Chile (USACH) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04504968?term=diabetes&sfpd_d=14 August 07, 2020 at 02:24PM via ClinicalTrials.gov |
New diabetes clinical trial: Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy | | |
New diabetes clinical trial: Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes | | |
New diabetes clinical trial: Prediabetes and Type 2 Diabetes Data Collection Study | | |
Няма коментари:
Публикуване на коментар